As our world seeks a full understanding of SARS-CoV-2, the diseases it causes and the associated comorbidities, healthcare professionals continue to deliver services, often adapting traditional practices to provide optimal care. Through the pandemic, FIP, too, is continuing to deliver on its mission to support global health through the advancement of pharmacy by providing a platform for collaboration across borders and uniting the profession.
As part of that mission, FIP Virtual 2020 took place over three weeks in September, showcasing pharmacy’s work in COVID-19, and launching a number of new programmes, such as the FIP Global Development Goals, that will allow the federation to move forward with its “One FIP” strategy. This issue of the IPJ contains reports from FIP Virtual as well as from FIP’s 7th Pharmaceutical Sciences World Congress, where scientists from across the globe discussed the latest developments, including around COVID.
• The acceleration of “virtual” practice
• How can pharmacists transform their practice around the air pollution agenda?
• Interview with 2020 André Bédat awardee Martin Schulz
• Celebrating 50 years of the Board of Pharmaceutical Sciences
• The world cannot afford low vaccine uptake so pharmacy must increase it
• Good leadership in challenging times
• Be an agent of change for women in science and education
• How Jordan and Indonesia collaborated with FIP to advance pharmacy practice
• COVID-19 has changed the future of drug development
• Issues to consider for herd immunity — COVID-19
• Advancing cancer therapies through mathematics and trial design
• Genomics: The next leap forward in clinical care
• Challenges for cell and gene therapy manufacturing
• Harnessing the therapeutic potential of gut microbes
• New use for old diabetes medicine could improve outcomes in hepatitis B
• Novel diagnostic technology to monitor health conditions via the skin developed
• Overcoming global health challenges with innovative drug delivery approaches
• How access to medicines can be widened by more efficient production
And news includes:
• Transformation of profession to be guided by new goals
• Growing concern over the future of medicines supplies worldwide reflected in new FIP policy statement
• Survey points to shortages caused by COVID
• FIP makes policy statement to address global emergency of patient safety
• Calls for focus on remuneration and sustainability
• Fight against antimicrobial resistance to be advanced by new FIP commission
• New vision laid out to take community pharmacy to 2025
• FIP presents how healthcare challenges in sub-Saharan Africa can be addressed through pharmacy education reform
• Canadian pharmacists want naloxone kits in opioid users’ homes
• Largest screening study for diabetes risk by pharmacists launched
• FIP award winners for 2020
All this is available now!
FIP members can access the interactive journal and pdf here.